REVIEWS HPV prophylactic vaccines: Second-generation or first-generation vaccines (original) (raw)

HPV prophylactic vaccines: Second-generation or first-generation vaccines

Golnaz Mardani

Journal of Solid Tumors, 2015

View PDFchevron_right

Developing an HPV vaccine to prevent cervical cancer and genital warts

Janine Bryan

Vaccine, 2007

View PDFchevron_right

Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2

Denis Mamuli

Vaccine, 2015

View PDFchevron_right

Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms

Ian Frazer

Vaccine, 2006

View PDFchevron_right

Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer

Tzyy-choou Wu

Biologics : targets & therapy, 2008

View PDFchevron_right

Progress in the development of a cervical cancer vaccine

Peter Stern

Therapeutics and Clinical Risk Management, 2006

View PDFchevron_right

Current Status of Human Papillomavirus Vaccines

Ermina Iljazovic

Journal of the Formosan Medical Association, 2010

View PDFchevron_right

Broad-Spectrum Human Papillomavirus Vaccines: New Horizons but One Step at a Time

F. Xavier Bosch

JNCI: Journal of the National Cancer Institute, 2009

View PDFchevron_right

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer

Angel Cid-Arregui

The Open Virology Journal, 2009

View PDFchevron_right

Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine

Janine Bryan

Current Opinion in Chemical Biology, 2016

View PDFchevron_right

Human Papilloma Virus (HPV) Vaccines: Scope and Implications

Roshan Singh

View PDFchevron_right

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins

Philip Minor

Vaccine, 2014

View PDFchevron_right

Broad cross protection is induced by a human papillomavirus vaccine composed of L1/L2 chimeric virus-like particles in preclinical models

Emmanuel Mertens

Journal of Virology, 2016

View PDFchevron_right

Papillomavirus-like particles and HPV vaccine development

Douglas Lowy

Seminars in Cancer Biology, 1996

View PDFchevron_right

Protection Against Papillomavirus with a Polynucleotide Vaccine

daniel martinez

Journal of Lower Genital Tract Disease, 1997

View PDFchevron_right

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses

dieter fink

Journal of Investigative Dermatology, 2013

View PDFchevron_right

HPV vaccines to prevent cervical cancer and genital warts: an update

Rita Verhelst

Vaccine, 2014

View PDFchevron_right

Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer

Kenneth Palmer, J. Kouokam

Experimental and Molecular Pathology, 2009

View PDFchevron_right

Therapeutic Human Papillomavirus Vaccines: A Review

Abhay Chowdhary

International Journal of Pharmaceutical Sciences Review and Research

View PDFchevron_right

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

Michelle A Ozbun

Vaccine, 2014

View PDFchevron_right

HPV vaccines: the beginning of the end for cervical cancer

Ian Frazer

Current Opinion in Immunology, 2007

View PDFchevron_right

HPV protein/peptide vaccines: from animal models to clinical trials

W. Martin Kast

Frontiers in Bioscience, 2003

View PDFchevron_right

Vaccines against human papillomavirus: perspectives for controlling cervical cancer

Silvia C Galvan

Expert Review of Vaccines, 2007

View PDFchevron_right

Prevention of cancer by prophylactic human papillomavirus vaccines

Anna Yemelyanova

Current Opinion in Immunology, 2011

View PDFchevron_right

Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs

Lamha Kumar

Frontiers in Oncology

View PDFchevron_right

Advances in human papilloma virus vaccines: a review

Anjali Tomar

International Journal of Basic & Clinical Pharmacology, 2014

View PDFchevron_right

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

TOUFIK ZAHAF

The Lancet, 2004

View PDFchevron_right

Human papillomavirus and HPV vaccines: a review

Xavier Castellsagué

Bulletin of the World Health Organization, 2007

View PDFchevron_right

A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types

dieter fink

PloS one, 2015

View PDFchevron_right